76 related articles for article (PubMed ID: 24375967)
1. Proteomic analysis of SP600125-controlled TrkA-dependent targets in SK-N-MC neuroblastoma cells: inhibition of TrkA activity by SP600125.
Jung EJ; Park HC; Chung KH; Kim CW
Proteomics; 2014 Feb; 14(2-3):202-15. PubMed ID: 24375967
[TBL] [Abstract][Full Text] [Related]
2. Proteomic analysis of novel targets associated with TrkA-mediated tyrosine phosphorylation signaling pathways in SK-N-MC neuroblastoma cells.
Jung EJ; Lee SY; Kim CW
Proteomics; 2013 Jan; 13(2):355-67. PubMed ID: 23319303
[TBL] [Abstract][Full Text] [Related]
3. Proteomic analysis of novel targets associated with the enhancement of TrkA-induced SK-N-MC cancer cell death caused by NGF.
Jung EJ; Chung KH; Bae DW; Kim CW
Exp Mol Med; 2016 May; 48(5):e235. PubMed ID: 27229480
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of basal activity of c-jun-NH2-terminal kinase (JNK) represses the expression of presenilin-1 by a p53-dependent mechanism.
Lee S; Das HK
Brain Res; 2008 May; 1207():19-31. PubMed ID: 18374905
[TBL] [Abstract][Full Text] [Related]
5. Control of TrkA-induced cell death by JNK activation and differential expression of TrkA upon DNA damage.
Jung EJ; Kim DR
Mol Cells; 2010 Aug; 30(2):121-5. PubMed ID: 20680486
[TBL] [Abstract][Full Text] [Related]
6. Cytosolic accumulation of gammaH2AX is associated with tropomyosin-related kinase A-induced cell death in U2OS cells.
Jung EJ; Kim CW; Kim DR
Exp Mol Med; 2008 Jun; 40(3):276-85. PubMed ID: 18587265
[TBL] [Abstract][Full Text] [Related]
7. A c-Jun NH2-terminal kinase inhibitor SP600125 (anthra[1,9-cd]pyrazole-6 (2H)-one) blocks activation of pancreatic stellate cells.
Masamune A; Kikuta K; Suzuki N; Satoh M; Satoh K; Shimosegawa T
J Pharmacol Exp Ther; 2004 Aug; 310(2):520-7. PubMed ID: 15056726
[TBL] [Abstract][Full Text] [Related]
8. Calcium-stimulated mitogen-activated protein kinase activation elicits Bcl-xL downregulation and Bak upregulation in notexin-treated human neuroblastoma SK-N-SH cells.
Chen KC; Liu WH; Kao PH; Chang LS
J Cell Physiol; 2010 Jan; 222(1):177-86. PubMed ID: 19780038
[TBL] [Abstract][Full Text] [Related]
9. c-Jun N-terminal kinase inhibitor SP600125 enhances barrier function and elongation of human pancreatic cancer cell line HPAC in a Ca-switch model.
Konno T; Ninomiya T; Kohno T; Kikuchi S; Sawada N; Kojima T
Histochem Cell Biol; 2015 May; 143(5):471-9. PubMed ID: 25511417
[TBL] [Abstract][Full Text] [Related]
10. Protective effects of SP600125 a new inhibitor of c-jun N-terminal kinase (JNK) and extracellular-regulated kinase (ERK1/2) in an experimental model of cerulein-induced pancreatitis.
Minutoli L; Altavilla D; Marini H; Passaniti M; Bitto A; Seminara P; Venuti FS; Famulari C; Macrì A; Versaci A; Squadrito F
Life Sci; 2004 Oct; 75(24):2853-66. PubMed ID: 15454338
[TBL] [Abstract][Full Text] [Related]
11. Blockage by SP600125 of Fcepsilon receptor-induced degranulation and cytokine gene expression in mast cells is mediated through inhibition of phosphatidylinositol 3-kinase signalling pathway.
Tanemura S; Momose H; Shimizu N; Kitagawa D; Seo J; Yamasaki T; Nakagawa K; Kajiho H; Penninger JM; Katada T; Nishina H
J Biochem; 2009 Mar; 145(3):345-54. PubMed ID: 19106158
[TBL] [Abstract][Full Text] [Related]
12. Induction of endoreduplication by a JNK inhibitor SP600125 in human lung carcinoma A 549 cells.
Miyamoto-Yamasaki Y; Yamasaki M; Tachibana H; Yamada K
Cell Biol Int; 2007 Dec; 31(12):1501-6. PubMed ID: 17904874
[TBL] [Abstract][Full Text] [Related]
13. Nerve growth factor-induced protein kinase C stimulation contributes to TrkA-dependent inhibition of p75 neurotrophin receptor sphingolipid signaling.
Plo I; Bono F; Bezombes C; Alam A; Bruno A; Laurent G
J Neurosci Res; 2004 Aug; 77(4):465-74. PubMed ID: 15264216
[TBL] [Abstract][Full Text] [Related]
14. Identification of simvastatin-regulated targets associated with JNK activation in DU145 human prostate cancer cell death signaling.
Jung EJ; Chung KH; Kim CW
BMB Rep; 2017 Sep; 50(9):466-471. PubMed ID: 28803608
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of c-Jun NH2-terminal kinase switches Smad3 signaling from oncogenesis to tumor- suppression in rat hepatocellular carcinoma.
Nagata H; Hatano E; Tada M; Murata M; Kitamura K; Asechi H; Narita M; Yanagida A; Tamaki N; Yagi S; Ikai I; Matsuzaki K; Uemoto S
Hepatology; 2009 Jun; 49(6):1944-53. PubMed ID: 19418558
[TBL] [Abstract][Full Text] [Related]
16. SP600125, a selective JNK inhibitor, protects ischemic renal injury via suppressing the extrinsic pathways of apoptosis.
Wang Y; Ji HX; Xing SH; Pei DS; Guan QH
Life Sci; 2007 May; 80(22):2067-75. PubMed ID: 17459422
[TBL] [Abstract][Full Text] [Related]
17. Cross-talk between phosphatidylinositol 3-kinase/AKT and c-jun NH2-terminal kinase mediates survival of isolated human islets.
Aikin R; Maysinger D; Rosenberg L
Endocrinology; 2004 Oct; 145(10):4522-31. PubMed ID: 15242986
[TBL] [Abstract][Full Text] [Related]
18. Attenuation of ozone-induced airway inflammation and hyper-responsiveness by c-Jun NH2 terminal kinase inhibitor SP600125.
Williams AS; Issa R; Leung SY; Nath P; Ferguson GD; Bennett BL; Adcock IM; Chung KF
J Pharmacol Exp Ther; 2007 Jul; 322(1):351-9. PubMed ID: 17460151
[TBL] [Abstract][Full Text] [Related]
19. Upregulation of RhoB via c-Jun N-terminal kinase signaling induces apoptosis of the human gastric carcinoma NUGC-3 cells treated with NSC12618.
Kim BK; Kim HM; Chung KS; Kim DM; Park SK; Song A; Won KJ; Lee K; Oh YK; Lee K; Song KB; Simon JA; Han G; Won M
Carcinogenesis; 2011 Mar; 32(3):254-61. PubMed ID: 21084431
[TBL] [Abstract][Full Text] [Related]
20. Growth suppression of human mast cells expressing constitutively active c-kit receptors by JNK inhibitor SP600125.
Wang B; Tsukada J; Higashi T; Mizobe T; Matsuura A; Mouri F; Sawamukai N; Ra C; Tanaka Y
Genes Cells; 2006 Sep; 11(9):983-92. PubMed ID: 16923120
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
